Charles Schwab Investment Management Inc. increased its position in Aerovate Therapeutics by 3.7% during the 4th quarter.

Source: https://www.americanbankingnews.com/2023/04/06/aerovate-therapeutics-inc-nasdaqavte-ceo-timothy-p-noyes-sells-15000-shares-of-stock.html

Finally, Legal & General Group Plc lifted its holdings in Aerovate Therapeutics by 318.0% in the 4th quarter.

Source: https://www.etfdailynews.com/2023/05/11/benjamin-t-dake-sells-10284-shares-of-aerovate-therapeutics-inc-nasdaqavte-stock/

Strs Ohio acquired a new stake in Aerovate Therapeutics during the second quarter valued at approximately $39,000.

Source: https://www.etfdailynews.com/2023/11/27/aerovate-therapeutics-inc-nasdaqavte-insider-sells-142324-94-in-stock/

Wells Fargo & Company started coverage on Aerovate Therapeutics in a research note on Friday, December 8th.

Source: https://www.etfdailynews.com/2023/12/28/aerovate-therapeutics-nasdaqavte-trading-down-3-1/